TG Therapeutics Quote, Financials, Valuation and Earnings

TG Therapeutics Price Quote

-0.24 (-1.62%)
(Updated: March 30, 2023 at 11:30 PM ET)

TG Therapeutics Key Stats

TG Therapeutics (TGTX) is a Sell

Day range:
$14.51 - $15.00
52-week range:
$3.48 - $19.59
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.97%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went down by -7.3% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price rose by 40.63% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $71.1M
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $161.7M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 0.40

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$176.2M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$391K
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$20M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is -95.28%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -73.69%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is -142.56%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • Axcella Health Inc (AXLA)
    • Johnson & Johnson (JNJ)
    • Kala Pharmaceuticals Inc (KALA)
    • Nuwellis Inc (NUWE)
    • Palisade Bio Inc (PALI)

TG Therapeutics Dividend Yield

Data Unavailable

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -48.1%
Revenue: -96.55% -95.01%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 20.78
Upside from Last Price: 39.92%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    144.7M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    19.9M TGTX shares are owned by insiders